{
    "id": "correct_subsidiary_00122_0",
    "rank": 93,
    "data": {
        "url": "https://discovery.patsnap.com/topic/venous-circulation/",
        "read_more_link": "",
        "language": "en",
        "title": "Top 20 Venous circulation companies - Discovery",
        "top_image": "https://discovery.patsnap.com/company/favicon.png",
        "meta_img": "https://discovery.patsnap.com/company/favicon.png",
        "images": [
            "https://discovery-static.patsnap.com/seo/client/company/svg/logo.svg",
            "https://discovery-static.patsnap.com/seo/client/img/icon-light.2495fb1.jpg",
            "https://discovery-static.patsnap.com/seo/client/img/icon-light.2495fb1.jpg",
            "https://discovery-static.patsnap.com/seo/client/img/company-competitive.6933519.jpg",
            "https://discovery-static.patsnap.com/seo/logo/organization/entity/master_entity_128/abd0/565b/18d5/b374/0641/1075/d791/38e5/3d1b424927297e39.png",
            "https://discovery-static.patsnap.com/seo/logo/organization/entity/master_entity_128/e638/d6ec/0de9/350c/6082/e4ce/9680/cbba/39f5d28122dcaa34.jpeg",
            "https://discovery-static.patsnap.com/seo/logo/organization/entity/master_entity_128/17b5/8950/0005/5235/03f1/8af5/3f20/8702/112ecf8d4c73b305.jpeg",
            "https://discovery-static.patsnap.com/seo/client/company/svg/company-placeholder.svg",
            "https://discovery-static.patsnap.com/seo/client/company/svg/company-placeholder.svg",
            "https://discovery-static.patsnap.com/seo/logo/organization/entity/master_entity_128/4629/3918/066d/6588/d64e/5497/5512/4a7e/5a5695f3af60cdd4.png",
            "https://discovery-static.patsnap.com/seo/logo/organization/entity/master_entity_128/8327/5635/2f02/f174/33df/b065/466d/f2c2/622fdcb1c3ec5420.png",
            "https://discovery-static.patsnap.com/seo/logo/organization/entity/master_entity_128/ae3d/4f06/4610/e709/a580/8bbf/02ed/b564/425914801acc477c.jpeg",
            "https://discovery-static.patsnap.com/seo/logo/organization/entity/master_entity_128/8881/da4f/52cd/2927/a962/0c0a/1476/110d/8102c668c1bc623e.jpeg",
            "https://discovery-static.patsnap.com/seo/client/company/svg/company-placeholder.svg",
            "https://discovery-static.patsnap.com/seo/client/company/svg/company-placeholder.svg",
            "https://discovery-static.patsnap.com/seo/client/company/svg/company-placeholder.svg",
            "https://discovery-static.patsnap.com/seo/logo/organization/entity/master_entity_128/a9a2/ba8d/c730/440a/09a5/3a73/8a1a/e42e/9ce5d45102e8c9ec.gif",
            "https://discovery-static.patsnap.com/seo/logo/organization/entity/master_entity_128/79cd/344d/a5c6/3b60/691a/14c6/89c2/8ddd/ba7dcc920926dad5.jpeg",
            "https://discovery-static.patsnap.com/seo/client/company/svg/company-placeholder.svg",
            "https://discovery-static.patsnap.com/seo/client/company/svg/company-placeholder.svg",
            "https://discovery-static.patsnap.com/seo/client/company/svg/company-placeholder.svg",
            "https://discovery-static.patsnap.com/seo/client/company/svg/company-placeholder.svg",
            "https://discovery-static.patsnap.com/seo/logo/organization/entity/master_entity_128/b366/016b/b56d/9fd8/aeb2/5467/1e0b/bd85/fec092a96e103e86.png",
            "https://discovery-static.patsnap.com/seo/client/company/svg/company-placeholder.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "Venous circulation",
            "technical research",
            "competitor monitor",
            "market trends",
            "company profile",
            "discovery",
            "PatSnap"
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "venous circulation. the movement of blood from the venules, which drain deoxygenated blood from the capillaries, through the veins to the vena cava, and from there through the right atrium and ventricle to the pulmonary circulation of the lungs, where the blood is oxygenated for return to the systemic circulation.",
        "meta_lang": "en",
        "meta_favicon": "/company/favicon.png",
        "meta_site_name": "",
        "canonical_link": "https://discovery.patsnap.com/topic/venous-circulation/",
        "text": "NicOx is a biopharmaceutical company, engages in the development and commercialization of nitric oxide (NO)-donating drugs primarily for inflammation and cardio-metabolic diseases. The company's primary products candidates include Naproxcinod, a Phase III product candidate for the treatment of osteoarthritis; and NCX 6560, a NO-donating compound for the treatment of cardiovascular diseases, which is in phase I clinical trials. Its product portfolio comprise PF-03187207 for the treatment of glaucoma, TPI 1020 for the treatment of respiratory disorders, and NCX 1510 for allergic rhinitis, which are in Phase II clinical trials; and NO-donating antihypertensives, which is in phase I clinical trials for the treatment of hypertension. The company's product pipeline also include NCX 1047, which is in preclinical stage of development for treating a range of skin disorders, such as atopic dermatitis, psoriasis, and seborrheic dermatitis; and NO-donors for diabetic retinopathy, cardiometabolic, inflammation, and pain. It has research and co-development agreement with Orexo AB to identify and develop compounds for the treatment of airway diseases; license and development agreement with TOPIGEN Pharmaceuticals Inc. The company also has agreements with Grupo Ferrer Internacional SA for the research, development, and marketing of NO-donating anti-inflammatory drugs for the treatment of dermatological diseases; Pfizer Inc to identify nitric oxide-donating compounds for diabetic retinopathy; and Merck & Co., for the development of new antihypertensive drugs using NicOx' nitric oxide-donating technology. NicOx S.A. was founded in 1996 and is headquartered in Sophia Antipolis, France.\n\nXiamen Weiyou Intelligent Technology Co., Ltd., established on 2010-03-19, Business scope includes natural science research and experimental development;Manufacturing of electronic components and assemblies;Manufacturing of other electronic equipment;Manufacture of optoelectronic devices and other electronic devices;Manufacture of power distribution switch control equipment;Manufacturing of other unlisted electrical machinery and equipment;home beauty,Manufacturing of Health Appliances;Other Electronics Retail;Manufacture of electrical accessories for lamps and other lighting appliances;mold making;medical diagnosis,Monitoring and treatment equipment manufacturing;Manufacture of Mechanical Therapy and Ward Nursing Equipment;Manufacturing of other unlisted medical equipment and instruments;Design of robots and smart devices,research and development,Manufacturing and sales(Items not subject to permit approval);Wholesale of Class I Medical Devices;Wholesale of Class II Medical Devices;Retailing of Class I Medical Devices;Retailing of Class II Medical Devices;Import and export of various commodities and technologies(Import and export commodity catalog is not attached),Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.\n\nBaxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates through three segments: BioScience, Medication Delivery, and Renal. - The BioScience segment manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines. - The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. This segment also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies. - The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. This segment also offers solutions and other products for peritoneal dialysis, a home-based therapy and product for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is headquartered in Deerfield, Illinois.\n\nMannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Westlake Village, California, the company was founded in February 1991. However, its present form is a result of a 2003 merger of three companies owned by Alfred E. Mann, Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing a allergy vaccine technology. MannKind Corporation was named after its founder, Alfred Mann. One of the former companies, Pharmaceutical Discovery, was purchased in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin).\n\nHeartport is an entrepreneurial medical device maker that has introduced several innovative systems for conducting less-invasive cardiac surgery. The company was founded by John H. Stevens and Wesley D. Sterman. Heartport manufactures and markets less invasive cardiac surgery products that enable surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. In April 2001, Heartport was merged with and into CARDIOVATIONS, a wholly-owned subsidiary of Johnson & Johnson. Heartport continues to operate as a part of the division of Ethicon, Inc., a Johnson & Johnson company. Ethicon is a global leader in developing and marketing products for surgery in the areas of wound closure and wound management, surgical sports medicine, women's health and cardiovascular surgery."
    }
}